KOSPIChemicals083420

Green Chemical

₩4,215▼ 1.98%2026-11-18 close
Market Cap
₩101.2B
Turnover
₩82,926,115
Volume
20K
Shares out.
24M
PER
6.5×
PBR
0.7×
EPS
₩664
Dividend Yield
5.59%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩240 per share · Prices as of the 2026-11-18 close

01

Report overview

Earnings Recovery, Then a Q3 2026 Net Loss

Green Chemical's net income attributable to controlling shareholders rose for three consecutive years from 2023 through 2025, but the company swung to a net loss attributable to controlling shareholders of KRW 126 million in Q3 2026.

  1. 1

    Net income attributable to controlling shareholders grew from KRW 2.87 billion in 2022 to KRW 9.65 billion in 2025, with three consecutive years of growth from 2023.

  2. 2

    The operating margin recovered from 1.8% in 2023 to 3.3% in 2025, still below the 5.3% recorded in 2022.

  3. 3

    After KRW 9.62 billion in controlling-shareholder net income in Q2 2026, Q3 2026 recorded a net loss attributable to controlling shareholders of KRW 126 million.

  4. 4

    The debt-to-equity ratio stood at 60.1% at the end of 2025, with total equity of KRW 128.3 billion.

  5. 5

    Demand for ETA-based carbon dioxide capture materials is expected to grow as greenhouse gas regulation tightens.

02

Business structure

Green Chemical was spun off from KPX Chemical in 2003 as a specialty fine chemicals company and listed on the KOSPI in 2005. The company manufactures and sells functional chemicals such as EOA, ETA, DMC and AM, using EO (ethylene oxide) as its main raw material.

Its business scope also includes trading of other chemical products alongside its functional chemicals. EOA and ETA are produced in a multi-product, small-batch system, which is viewed as limiting dependence on any single industry.

The company is pursuing higher-value products by expanding research and development on special grade products. EO-based products have margins that move with raw material prices and customer industry utilization, so quarterly revenue and operating profit often move together.

On the related-party side, transactions with Green Lifescience, which shares the same CEO, are significant. Green Lifescience's reliance on Green Chemical rose from 21.51% of its sales in 2024 to 50.65% in 2025 and 68.83% in Q1 2026.

Green Chemical buys inventory from Green Lifescience, and its 2025 annual report disclosed purchases of KRW 9.22 billion from that counterparty.

Compared with large domestic petrochemical peers such as Lotte Chemical, Kumho Petro Chemical and Hanwha Solutions, Green Chemical is a smaller specialty fine chemicals producer.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩77.3B₩5B6.5%
2025Q4₩68.9B₩2.1B3.0%
2026Q1₩77.7B₩3B3.9%
2026Q2₩91.9B₩7.5B8.2%
2026Q3₩87.8B₩3.8B4.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩324.9B₩17.2B₩2.9B5.3%2.3%60.6%
2023₩282.3B₩5B₩3.3B1.8%2.8%67.3%
2024₩330.3B₩10.7B₩8.2B3.2%6.7%67.4%
2025₩304.1B₩10.1B₩9.7B3.3%7.5%60.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue fell from KRW 324.9 billion in 2022 to KRW 282.3 billion in 2023, a decrease of 13.1%, then rose 17.0% to KRW 330.3 billion in 2024, the largest year in the 2022–2025 period. Revenue declined 8.0% to KRW 304.1 billion in 2025.

Operating profit dropped from KRW 17.2 billion in 2022 to KRW 4.95 billion in 2023, a decline of 71.2% and the smallest year of the period, then rose 115.8% to KRW 10.7 billion in 2024 before easing 5.0% to KRW 10.1 billion in 2025.

The operating margin moved from 5.3% in 2022 to 1.8% in 2023, 3.2% in 2024 and 3.3% in 2025, a modest recovery over two consecutive years from the 2023 low.

Net income attributable to controlling shareholders was KRW 2.87 billion in 2022, KRW 3.35 billion in 2023 (up 16.7%), KRW 8.19 billion in 2024 (up 144.6%) and KRW 9.65 billion in 2025 (up 17.8%), with three consecutive years of growth from 2023 through 2025.

The 2024 jump in controlling-shareholder profit moved in the same direction as the 115.8% operating profit recovery. The debt-to-equity ratio went from 60.6% in 2022 to 67.3% in 2023 and 67.4% in 2024 before falling to 60.1% in 2025.

At the end of 2025, total equity was KRW 128.3 billion and total liabilities were KRW 77.1 billion. Operating cash flow was KRW 18.8 billion in 2022, KRW 21.7 billion in 2023, KRW 19.1 billion in 2024 and KRW 16.7 billion in 2025, positive in every year of the period.

On a quarterly basis, Q3 2025 revenue was KRW 77.3 billion with operating profit of KRW 5.05 billion, and Q4 2025 revenue fell 10.9% quarter on quarter to KRW 68.9 billion while operating profit fell 58.8% to KRW 2.08 billion.

Q1 2026 revenue was KRW 77.7 billion with operating profit of KRW 3.02 billion, and Q2 2026 revenue rose to KRW 91.9 billion, the highest of the last five quarters, with operating profit of KRW 7.52 billion and controlling-shareholder net income of KRW 9.62 billion.

Q3 2026 revenue was KRW 87.8 billion, operating profit was KRW 3.8 billion, down 49.5% quarter on quarter and 24.7% year on year, and the company posted a net loss attributable to controlling shareholders of KRW 126 million.

Operating profit stayed positive in Q3 2026 while a line item below operating profit pushed the bottom line into a loss. In Q2 2026, controlling-shareholder net income exceeded operating profit, suggesting a meaningful contribution from non-operating items.

Over the most recent four quarters, from Q4 2025 through Q3 2026, net income attributable to controlling shareholders totaled KRW 15.5 billion.

05

Industry analysis

Within the chemicals sector, Green Chemical specializes in EO-based functional specialty chemicals, so its business structure differs from large producers that manufacture commodity petrochemicals at scale.

Listed peers such as LG Chem, Hanwha Solutions, SKC, Lotte Chemical and Kumho Petro Chemical tend to have large plants and a higher share of commodity products. By contrast, Green Chemical is a small company by market capitalization.

Its multi-product, small-batch production is viewed as limiting its exposure to demand swings in any single industry. Specialty chemicals can see price moves that differ from commodity products, but EO raw material prices and customer plant utilization still affect margins.

On the regulatory side, tighter greenhouse gas rules are expected to increase demand for ETA-based carbon dioxide capture materials. However, the extent to which this demand shows up in quarterly revenue and profit is hard to judge from reported results alone.

The corporate monitoring service Wisereport noted as of June 3, 2026 that separate-basis revenue fell in Q1 2026 while profitability improved on cost reductions. Against larger rivals, Green Chemical has a smaller scale but occupies a niche position as a materials company with product specialization.

Its position in the industry cycle is hard to pin down, so sector indicators and the trend in quarterly operating margins should be read together.

06

Outlook

Quarterly operating profit in 2026 moved sharply, at KRW 3.02 billion in Q1, KRW 7.52 billion in Q2 and KRW 3.8 billion in Q3. Q2 2026 revenue of KRW 91.9 billion was the highest of the last five quarters, while Q3 2026 revenue eased to KRW 87.8 billion.

The Q3 2026 net loss attributable to controlling shareholders of KRW 126 million remains the largest swing factor for the 2026 full-year profit trend. With KRW 15.5 billion in controlling-shareholder net income over the last four quarters, the direction of the full-year figures will depend on the Q4 2026 result.

ETA-based carbon dioxide capture materials are presented as a medium- to long-term growth pillar, though the scale of their revenue contribution is still hard to gauge. Research on high-value special grade products links to operating margin improvement as a business indicator.

The next regular report is the 2026 annual report, due by the end of March 2027. Q4 2026 results are expected to be released as preliminary figures in early 2027, after fiscal year-end on December 31, 2026, and the preliminary Q4 2025 results were released on March 1, 2026.

The Q1 2027 quarterly report, based on the May 14, 2026 filing date for Q1 2026, is likely to come out in mid-May 2027. How the related-party transaction amounts are presented in the annual report notes is also a point to check next.

07

Valuation

PER
6.5×
PBR
0.7×
ROE
11.9%
EPS
₩664
BPS
₩5,794
Dividend per share
₩240

On Investing.com's data as of October 13, 2026, the price-to-book ratio was below the average of listed peers. Relative to the KRW 128.3 billion of controlling-shareholder equity at the end of 2025, the stock trades at a lower multiple of book value.

On an earnings basis, the multiple rests on the KRW 15.5 billion of controlling-shareholder net income over the last four quarters, and because that total includes the Q3 2026 loss, quarterly swings feed directly into the multiple.

Because earnings have moved sharply from quarter to quarter, the range of possible multiple readings is wide. On the multi-year view, profit has moved from the 2022 base toward recovery, with 2025 the highest year in the 2022–2025 period.

Wisereport reported as of June 3, 2026 that the free float ratio was 37.39% and foreign ownership was 1.66%. Dividend sustainability is best read alongside the annual trend in controlling-shareholder net income.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Profit recovery trend

Net income attributable to controlling shareholders has risen every year since 2023, leaving the 2025 level above that of 2022. The operating margin climbed from 1.8% in 2023 to 3.3% in 2025, pointing to a profitability recovery.

In Q2 2026, revenue of KRW 91.9 billion and operating profit of KRW 7.52 billion marked a notable quarterly rebound.

Financial capacity

The debt-to-equity ratio was 60.1% at the end of 2025, down from 67.4% in 2024, with total equity of KRW 128.3 billion. The reduction points to a lighter financial burden. Operating cash flow was positive in every year from 2022 through 2025.

Demand expectations from environmental rules

Wisereport notes that tighter greenhouse gas regulation is expected to raise demand for ETA-based carbon dioxide capture materials. How much of that demand shows up in reported results is hard to separate from quarterly figures alone. The company is also developing special grade products to raise the share of higher-value sales.

09

Bear factors

Q3 2026 swing to net loss

Net income attributable to controlling shareholders swung to a loss of KRW 126 million in Q3 2026. Operating profit of KRW 3.8 billion fell 49.5% quarter on quarter and 24.7% year on year. Operating profit stayed positive, but items below it pulled the bottom line into negative territory.

Volatility in revenue and profit

Revenue fell 8.0% to KRW 304.1 billion in 2025 after reaching KRW 330.3 billion in 2024. Operating profit dropped to KRW 4.95 billion in 2023, when the operating margin of 1.8% was the lowest of the 2022–2025 period. Earnings capacity has swung sharply with product demand and costs.

Related-party dealings and disclosure gaps

Green Chemical and Green Lifescience share the same CEO, which makes the scale of their dealings significant. Press reports said the two companies recorded the same Q1 2026 transactions in amounts that differed by about KRW 6.2 billion. Green Chemical's share of Green Lifescience's sales reached 68.83% in Q1 2026.

10

Risk factors

Related-party transaction consistency

Transactions with Green Lifescience have grown in importance on both the sales and purchase sides. Reports of differing amounts for the same transactions make disclosure consistency a point to watch. Any change in the structure of these dealings could affect the quality of reported earnings.

Raw material costs and demand swings

Margins can move with EO and other raw material prices and with the utilization of customer industries. The operating margin falling to 1.8% in 2023 illustrates this sensitivity. With revenue down in 2025, the capacity to absorb cost swings could narrow.

Small-cap liquidity

The company is small by market capitalization, with a free float ratio of 37.39% and foreign ownership of 1.66% as of June 3, 2026 per Wisereport. Stocks with limited free float can see larger price swings when trading volume changes. Such characteristics can be more pronounced around quarterly earnings releases.

11

What to watch next

  1. Early March 2027

    Preliminary Q4 and full-year 2026 results are expected. The preliminary Q4 2025 results were released on March 1, 2026, so the operating profit trend will be compared with the KRW 3.8 billion of Q3 2026.

  2. End of March 2027

    This is the filing deadline for the 2026 annual report. Full-year revenue, operating profit and controlling-shareholder net income will be fixed, and the causes of the Q3 2026 loss can be traced through non-operating items and income tax. Consistency of related-party transaction amounts between the two companies is also a point to check.

  3. Mid-May 2027

    The Q1 2027 quarterly report is expected. This estimate is based on the May 14, 2026 filing of the Q1 2026 report. The key checks are whether the quarterly operating margin and controlling-shareholder net income hold near Q2 2026 levels.

  4. First half of 2027

    Quarterly disclosures will show whether demand for ETA-based carbon dioxide capture materials reaches revenue. Changes in the share of special grade product sales are a related checkpoint.

12

Overall view

Green Chemical's net income attributable to controlling shareholders rose for three consecutive years from 2023 through 2025, and its operating margin recovered from 1.8% in 2023 to 3.3% in 2025.

Q2 2026 stood out with revenue of KRW 91.9 billion, operating profit of KRW 7.52 billion and controlling-shareholder net income of KRW 9.62 billion. In Q3 2026, however, operating profit fell to KRW 3.8 billion and the company posted a net loss attributable to controlling shareholders of KRW 126 million.

Strengths include the profit recovery trend, financial capacity with a 60.1% debt-to-equity ratio and KRW 128.3 billion of total equity at the end of 2025, and expected demand for ETA materials tied to greenhouse gas rules.

Weaknesses include large quarterly profit swings, disclosure differences in related-party transaction amounts, and low liquidity typical of a small-cap stock.

On valuation, the price-to-book ratio sits below the peer average, while the earnings base rests on KRW 15.5 billion of controlling-shareholder net income over the last four quarters. The next checkpoint is the 2026 annual report, particularly the causes of the Q3 2026 loss and the related-party transaction notes.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 14 more articles and sources
  1. investing.com
  2. kokstock.com
  3. englishdart.fss.or.kr
  4. dolfin.plus
  5. markets.hankyung.com
  6. finance.finup.co.kr
  7. ssl.pstatic.net
  8. comp.wisereport.co.kr
  9. investing.com
  10. all.allroundnote.com
  11. kr.investing.com
  12. m.thinkpool.com
  13. greened.kr
  14. pflow.keywordegg.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis